BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6437716)

  • 1. Infection prophylaxis in the patient with bone marrow failure.
    Hann IM; Prentice HG
    Clin Haematol; 1984 Oct; 13(3):523-47. PubMed ID: 6437716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New approaches to the prophylaxis and treatment of bacterial and fungal infections in allogeneic marrow transplant recipients.
    Schuler U; Ehninger G
    Bone Marrow Transplant; 1994; 14 Suppl 4():S61-5. PubMed ID: 7728128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prevention of infection in recipients of solid organ transplants].
    Lumbreras C; Otero JR; Aguado JM
    Enferm Infecc Microbiol Clin; 1997 May; 15 Suppl 2():77-89. PubMed ID: 9312302
    [No Abstract]   [Full Text] [Related]  

  • 4. Prophylaxis and treatment of infection in the bone marrow transplant recipient.
    Winston DJ
    Curr Clin Top Infect Dis; 1993; 13():293-321. PubMed ID: 8397916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Importance of prevention of infectious complications in pediatric hematologic-oncologic patients].
    Fleischhack G; Simon A
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A5-8. PubMed ID: 11577360
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical appraisal of antimicrobials for prevention of infections in immunocompromised hosts.
    Hathorn JW
    Hematol Oncol Clin North Am; 1993 Oct; 7(5):1051-99. PubMed ID: 8226565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Bacteriologic management of patients with decreased resistance].
    Hendriks WD; Sizoo W; Löwenberg B; Hagenbeek A
    Ned Tijdschr Geneeskd; 1984 Feb; 128(7):305-10. PubMed ID: 6422314
    [No Abstract]   [Full Text] [Related]  

  • 10. Infection in the bone marrow transplant recipient.
    Walter EA; Bowden RA
    Infect Dis Clin North Am; 1995 Dec; 9(4):823-47. PubMed ID: 8747768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of infection in bone marrow transplant recipients.
    Young LS
    Clin Haematol; 1984 Oct; 13(3):661-78. PubMed ID: 6388936
    [No Abstract]   [Full Text] [Related]  

  • 12. [Infections following bone marrow transplantation].
    Ljungman P; Andersson J; Sparrelid E
    Nord Med; 1995; 110(12):320-1. PubMed ID: 8524635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infections in the immunocompromised host.
    Solberg CO
    Scand J Infect Dis Suppl; 1980; Suppl 24():36-43. PubMed ID: 6782661
    [No Abstract]   [Full Text] [Related]  

  • 15. Special considerations for the patient undergoing allogeneic or autologous bone marrow transplantation.
    Hiemenz JW; Greene JN
    Hematol Oncol Clin North Am; 1993 Oct; 7(5):961-1002. PubMed ID: 8226568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infections following orthotopic liver transplantation.
    Arnow PM
    HPB Surg; 1991 Apr; 3(4):221-32; discussion 232-3. PubMed ID: 1650245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of infection in children with bone marrow failure.
    Hann IM
    Baillieres Best Pract Res Clin Haematol; 2000 Sep; 13(3):441-56. PubMed ID: 11030044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Possibilities and limits for preventing infections in persons with a cellular immunity deficit].
    Teodorovici G
    Rev Med Chir Soc Med Nat Iasi; 1986; 90(1):14-8. PubMed ID: 3094113
    [No Abstract]   [Full Text] [Related]  

  • 20. [Infection prophylaxis in neutropenic patients].
    Capdevila JA; Pahissa A
    Enferm Infecc Microbiol Clin; 1997 Dec; 15(10):544-51. PubMed ID: 9522519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.